Cite
HARVARD Citation
Basho, R. et al. (n.d.). 1871 Inhibition of mTOR in combination with chemotherapy and angiogenic blockade shows activity in metaplastic breast cancer, an aggressive, chemo-refractory subtype of triple-negative breast cancer (TNBC). European journal of cancer. pp. S289-S290. [Online].